As shown in Figure 5(b), the tumor growth curves indicated that the tumors treated with si-IFT88 developed faster than control (finally, 1109.0 ± 164.0 mm3 vs. 668.5 ± 48.7 mm3; n = 5, P=0.0328). This evidence concerns the gene IFT88 and neoplasm.